Humana Inc. (NYSE:HUM) will release its second quarter earnings report before the opening bell on Wednesday, July 29.
Analysts expect the Louisville, Kentucky-based company to report quarterly earnings of $7.00 per share, up from $6.27 per share in the year-ago period. The consensus estimate for Humana’s quarterly revenue is $40.57 billion. It reported $32.39 billion last year, according to Benzinga Pro.
On June 10, Humana agreed to divest a minority stake in Gentiva in a deal valued at $900 million.
Shares of Humana gained 2% to close at $388.71 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- TD Cowen analyst Ryan Langston maintained a Hold rating and raised the price target from $211 to $350 on July 14, 2026. This analyst has an accuracy rate of 50%.
- Truist Securities analyst David Macdonald maintained a Hold rating and raised the price target from $320 to $415 on July 14, 2026. This analyst has an accuracy rate of 70%.
- Wells Fargo analyst Stephen Baxter upgraded the stock from Equal-Weight to Overweight and raised the price target from $227 to $502 on July 13, 2026. This analyst has an accuracy rate of 70%.
- RBC Capital analyst Ben Hendrix maintained the stock with a Sector Perform rating and boosted the price target from $246 to $415 on July 9, 2026. This analyst has an accuracy rate of 66%.
- B of A Securities analyst Kevin Fishbeck maintained the stock with a Neutral rating and raised the price target from $340 to $380 on June 24, 2026. This analyst has an accuracy rate of 65%
Considering buying HUM stock? Here’s what analysts think:
Photo via Shutterstock